Cardiac Diagnostic Catheters Market Expected to Reach US$ 26.70 Billion by 2031 | Growth Plus Reports

Newark, New Castle, USA, April 18, 2023 (GLOBE NEWSWIRE) — According to a recent report by Growth Plus Reports, the global cardiac diagnostic catheters market was valued at US$ 14.16 billion in 2022 and is expected to surpass US$ 26.70 billion by 2031, at a revenue CAGR of 7.30%. The report analyzes top winning strategies, drivers & opportunities, competitive scenarios, wavering market trends, market size, statistics & estimations, and major investment pockets.

Key Takeaways:

• The rising prevalence of cardiovascular diseases will provide plenty of growth opportunities for the cardiac diagnostic catheters market.
• North America will dominate the global cardiac diagnostic catheters market.
• Increasing public awareness of the advantages of early detection and treatment will fuel the growth of the cardiac diagnostic catheters market.

Request a Sample Copy of the Research Report:  https://www.growthplusreports.com/inquiry/request-sample/cardiac-diagnostic-catheters-market/8639

                       Cardiac Diagnostic Catheters Market Scope

Market Drivers

The increasing prevalence of cardiovascular diseases is the primary factor driving the revenue growth of the global market. Furthermore, the growing demand for minimally invasive treatments, an ageing population, technological advances in catheters, a rise in healthcare budget, and increased awareness of the benefits of early detection and treatment for cardiovascular diseases will support market revenue growth.

Market Segmentation

Growth Plus Reports has analyzed the global cardiac diagnostic catheters market from three perspectives: Type, End User, and Region.

Type Segmentation: Based on the type, the global cardiac diagnostic catheters market is segmented into electrophysiology catheters, PTCA balloons catheters, IVUS catheters, and PTA balloons catheters. The electrophysiology catheters segment dominates the market with the largest revenue share because of an increase in the prevalence of atrial fibrillation and atrial flutter, an increase in the need for diagnostic and ablation catheters, an increase in the number of cardiac ablation procedures, and technological advances in the production of electrophysiology catheters.

End User Segmentation: Based on the end user, the global cardiac diagnostic catheters market is segmented into hospitals, diagnostics and imaging centers, and ambulatory surgery centers. The hospitals segment dominates the market with the largest revenue share because hospitals are typically the primary healthcare facility for patients who require cardiovascular disease tests such as angiography, electrophysiology tests, and other catheter-based therapies.

Regional Growth Dynamics

Based on the region, the global cardiac diagnostic catheters market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America dominates the global cardiac diagnostic catheters market due to the high healthcare spending, a well-developed healthcare infrastructure, a high prevalence of chronic diseases, and increasing investment for research and development for novel medicinal procedures and treatments.

Request for Customization –  https://www.growthplusreports.com/inquiry/customization/cardiac-diagnostic-catheters-market/8639

Competitive Landscape

The major players operating in the global cardiac diagnostic catheters market are:

• Abbott Laboratories
• Boston Scientific Corporation
• Ares Medikal
• Medtronic plc
• BrosMed Medical Co. Ltd.
• Cascade Health Care
• Johnson & Johnson
• Guangzhou Weili Medical Equipment Co., Ltd.
• Koninklijke Philips N.V.
• Lepu Medical Technology (Beijing) Co., Ltd.
• Merit Medical Systems
• Teleflex Incorporated

The cardiac diagnostic catheters market is moderately competitive with few key players. Key players operating in the market are implementing competitive sustainability tactics such as product development and regional presence growth. Major firms are aggressively acquiring other companies to strengthen their global market positions.

Recent developments:

• Philips announced the efficacy of their Verisight Pro real-time 3D intracardiac echocardiography (ICE) catheter in treating patients with structural heart disease in September 2022 in Florida, the United States, at Baptist Health’s Miami Cardiac & Vascular Institute.
• Medtronic fully acquired Affera, Inc. in August 2022. The purchase expanded the company’s offering of cardiac ablation technologies by adding its first-ever cardiac mapping and navigation technology, which provides a novel, totally integrated diagnostic, focused pulsed field, and radiofrequency ablation solution.
• The FDA authorized an expanded indication for the use of specialized catheters and coronary guidewires in CTO PCI procedures for Teleflex in February 2022.

Table of Content

1. INTRODUCTION
   1. Market Ecosystem
   2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
   3. Currency Used in the Report
2. RESEARCH METHODOLOGY 
   1. Research Approach
   2. Data Collection Methodology
   3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
   4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
   5. Market Forecasting Model
   6. Limitations and Assumptions
3. PREMIUM INSIGHTS
   1. Current Market Trends (COVID-19 Perspective)
   2. Key Players & Competitive Positioning (2022) 
   3. Regulatory Landscape
   4. Reimbursement Scenario 
4. MARKET DYNAMICS
   1. Drivers
   2. Restraints/Challenges
   3. Opportunities
5. GLOBAL CARDIAC DIAGNOSTIC CATHETERS MARKET – ANALYSIS & FORECAST, BY TYPE
   1. Electrophysiology Catheters
   2. PTCA Balloons Catheters
   3. IVUS Catheters
   4. PTA Balloons Catheters
   5. Others
6. GLOBAL CARDIAC DIAGNOSTIC CATHETERS MARKET – ANALYSIS & FORECAST, BY END USER
   1. Hospitals
   2. Diagnostic and Imaging Centers
   3. Ambulatory Surgical Centers

CARDIAC DIAGNOSTIC CATHETERS MARKET TOC

Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8639

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives
• Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market

CUSTOMIZATION OPTIONS:

• Distributor Landscape Assessment
• Pricing Intelligence
• Customer Base Assessment
• Investment & Initiatives Analysis
• ‘Business Profile’ of Key Players

Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction

Visit our report store at – https://www.growthplusreports.com/report-store

Browse Latest Healthcare Related Reports:

Pneumonia Testing Market by Type (Bacterial, Viral), Test Type (Blood Test, Sputum Test), Method (Immunodiagnostic, Molecular Diagnostics), Technology (Enzyme-Linked Immunosorbent Assay (ELISA), Immunofluorescence), End User (Hospitals, Diagnostic Centers) – Global Outlook and Forecast 2023-2031

Positive Expiratory Pressure Devices Market by Product Type (Face Mask PEP Devices, Mouthpiece PEP Devices), Application (Atelectasis, Bronchiectasis), End User (Hospitals & Clinics, Ambulatory Surgical Centers) – Global Outlook & Forecast 2023-2031

Aortic Valve Replacement Devices Market by Surgery (Open Surgery, Minimally Invasive Surgery), Product (Transcatheter Aortic Valve, Suture-less Valve), End User (Hospitals, Ambulatory Surgery Centers) – Global Outlook and Forecast 2023-2031

Antiplatelet Drugs Market by Drug Class (Irreversible Cyclooxygenase Inhibitors, Thromboxane inhibitors), Route of Administration (Oral, Parenteral), Indications (Acute Coronary Syndrome, Acute Ischemic Stroke) – Global Outlook and Forecast 2023-2031

Pharmaceutical Quality Management Systems Market by Deployment (On-cloud, On-premises), Solution Type (Audit Management, Document Management), End User (Pharmaceutical Companies, Contract Research Organizations) – Global Outlook & Forecast 2023-2031

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020.